Skip to content

Allergy testing in lips and eyelid allergy

Role of Patch testing in Lip and Eyelid Dermatitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073308
Enrollment
20
Registered
2024-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L239- Allergic contact dermatitis, unspecified cause

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Aravind Suprakasan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients above 18 years of age and less than 60years 2. Patients attending dermatology OP with lip and eye lid dermatitis. 3. Patients consenting for patch test.

Exclusion criteria

Exclusion criteria: 1. Patients on any immunosuppressive treatment (eg : oral corticosteroids, azathioprine, cyclosporine, tofacitinib) 2. Patients having extensive active dermatitis, exfoliative dermatitis 3. Pregnant patients 4. Patients having lesions on the back which will interfere with the application of patch or reading 5. Patients who are unable to come for 48 hour and 72-hour reading

Design outcomes

Primary

MeasureTime frame
Itching or Faint erythema or papules or pustules or vesicles at the site of patch testTimepoint: first reading at 48 hours after application of patch and second reading at 72 hours

Secondary

MeasureTime frame
Itching or Faint erythema or papules or pustules or vesicles at the site of patch testTimepoint: Patch test site positive reaction occurring after 72 hours

Countries

India

Contacts

Public ContactDr Niranjana Gopinathan M P

Kasturba Medical College, Manipal

aravind.s@manipal.edu8943985007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026